Nusinersen versus Sham Control in Infantile-Onset Spinal Muscular Atrophy
2017 · New England Journal of Medicine · 2,177 citations
https://doi.org/10.1056/nejmoa1702752
C
C. Frank Bennett
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
329
Papers
46.7K
Citations
100
h-index
228
i10-index
C. Frank Bennett is an academic researcher from Pennsylvania State University. The author has contributed to research in topics: Neurogenetic and Muscular Disorders Research & RNA Interference and Gene Delivery & RNA Research and Splicing. The author has an h-index of 100, co-authored 280 publications.
ORCID: 0000-0001-9887-6251Papers by this author
worksmiR-122 regulation of lipid metabolism revealed by in vivo antisense targeting
2006 · Cell Metabolism · 2,050 citations
https://doi.org/10.1016/j.cmet.2006.01.005
Antisense Masking of an hnRNP A1/A2 Intronic Splicing Silencer Corrects SMN2 Splicing in Transgenic Mice
2008 · The American Journal of Human Genetics · 558 citations
https://doi.org/10.1016/j.ajhg.2008.01.014
Tau-targeting antisense oligonucleotide MAPTRx in mild Alzheimer’s disease: a phase 1b, randomized, placebo-controlled trial
2023 · Nature Medicine · 288 citations
https://doi.org/10.1038/s41591-023-02326-3
Peripheral Androgen Receptor Gene Suppression Rescues Disease in Mouse Models of Spinal and Bulbar Muscular Atrophy
2014 · Cell Reports · 173 citations
https://doi.org/10.1016/j.celrep.2014.02.008
Blocking of heart allograft rejection by intercellular adhesion molecule-1 antisense oligonucleotides alone or in combination with other immunosuppressive modalities.
1994 · The Journal of Immunology · 143 citations
https://doi.org/10.4049/jimmunol.153.11.5336
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat